These studies and outside research on PCMs are arranged by Waypoint and Test.
Waypoint 1
The PSA test for prostate cancer is just the first step in learning more about your risk. Gain more insights below.
- Landmark PSA of 1.5 paper, December 2016
- American Cancer Society prostate cancer screening recommendations
- Big 2017 Change on PSA by USPSTF, May 2017
4Kscore® Test
Explore more information about the 4Kscore® Test.
Phi Test
Explore more information about the Prostate Health Index (phi).
- Published articles (2014-2018)
- Beckman Coulter phi website
- Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting
- How the Prostate Health Index (phi) Helps Answer: “To Biopsy or Not To Biopsy”
- Prostate Health Index density improves detection of clinically significant prostate cancer
ExoDx Test
Explore more information about the ExosomeDx test.
- ExoDx Patient website
- ExoDx Physician website
- ExoDx At-Home Collection Kit
- ExoDx Prostate Test for Risk Assessment of high-grade prostate cancer (HGPCa) Webinar
- A Novel Urine Exosome Gene Expression Assay to Predict High-Grade Prostate Cancer at Initial Biopsy
- A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy
Select mdx Test
Explore more information about the Select mdx test.
- Clinical and Scientific References: Rigorous Studies, Conducted at Leading Academic Medical Centers, Continue to Validate the Performance of SelectMDx for Prostate Cancer
- MDxHealth Announces Inclusion of SelectMDx in 2020 NCCN Guidelines for Prostate Cancer Early Detection
- Select mdx patient website
- Select mdx physician website
Prompt PGS
Explore more information about the Prompt PGS test.
- Prompt PGS patient website
- Prompt PGS physician website
- The Role of Genetic Testing in Prostate Cancer, April 2020
Myriad MyRisk Genetic Test
Explore more information about the Myriad Genetics MyRisk test.
- Myriad Genetics Prostate Cancer Information
- MyRisk website
- Determine if you’re eligible for the MyRisk Hereditary Cancer Test
- The Role of Genetic Testing in Prostate Cancer, April 2020
ProstateNext Genetic Test
Explore more information about the ProstateNext genetics test.
- Ambry Genetics Hereditary Cancer Questionnaire
- ProstateNext Patient Guide
- Ambry Genetics patient website
- Ambry Genetics physician website
- The Role of Genetic Testing in Prostate Cancer, April 2020
Ambry Score Genetic Test
Explore more information about the Ambry Score.
- Ambry Genetics Hereditary Cancer Questionnaire
- The Role of Genetic Testing in Prostate Cancer, April 2020
- Ambry Genetics patient website
- Ambry Genetics physician website
Confirm mdx
Explore more information about Confim mdx.
Oncotype DX GPS
Explore more information about Oncotype DX GPS.
- Oncotype DX patient website
- Oncotype DX physician website
- Using Genomics to Guide Treatment, March 2017
Decipher
Explore more information about Decipher Biopsy.
- Published articles
- Using Genomics to Guide Treatment, March 2017
- Decipher patient website
- Decipher patient brochure
- Decipher sample report
Prolaris Score
Explore more information about Prolaris.
Decipher RP
Explore more information about Decipher RP.
- Published articles
- Important references for the Decipher prostate cancer genomic test, March 2017
- Using Genomics to Guide Treatment, March 2017
- Decipher RP sample report
Oncotype DX AR-V7
Explore more information about Oncotype DX AR-V7.
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer